ConductScience.org, home

Paper29142012

Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.

Feldman T and 18 others. Circulation, 2018. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Papers, record 29142012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29142012

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
PubMed
Journal
Circulation
PubMed
Year
2018
PubMed
Publication types
Clinical Trial, Phase II, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
8.6
iCite
Revised in PubMed
2019-04-09
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feldman TTed
2Mauri LLaura
3Kahwash RRami
4Litwin SSheldon
5Ricciardi MJMark J
6van der Harst PPim
7Penicka MMartin
8Fail PSPeter S
9Kaye DMDavid M
10Petrie MCMark C
11Basuray AAnupam
12Hummel SLScott L
13Forde-McLean RRhondalyn
14Nielsen CDChristopher D
15Lilly SScott
16Massaro JMJoseph M
17Burkhoff DDaniel
18Shah SJSanjiv J
19REDUCE LAP-HF I Investigators and Study CoordinatorsGroup

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Atrial Function, LeftMajor topic
Atrial PressureMajor topic
Cardiac CatheterizationMajor topic
Cardiac CathetersMajor topic
Heart FailureMajor topic
Heart-Assist DevicesMajor topic
Stroke VolumeMajor topic
Ventricular Function, LeftMajor topic
Aged
Australia
Europe
Exercise Tolerance
Female
Humans
Male
Middle Aged
Prospective Studies
Prosthesis Design
Pulmonary Wedge Pressure
Recovery of Function
Time Factors
Treatment Outcome
United States

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02600234REDUCE LAP-HF RANDOMIZED TRIAL IDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Cited by133

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
42930915Interatrial Shunt Devices in Heart Failure: A Therapy in Search of the Right Patient.J Cardiovasc Dev Dis2026https://conductscience.org/library/papers/42930915PubMed
42842133Novel device-based and catheter-directed therapies for heart failure with preserved ejection fraction.Cardiovasc Interv Ther2026https://conductscience.org/library/papers/42842133PubMed
42578452Type 2 diabetes in heart failure with preserved and mildly reduced ejection fraction: insights from the REDUCE-LAP-HF II trial.ESC Heart Fail2026https://conductscience.org/library/papers/42578452PubMed
42428489Case Report: Managing a patent foramen ovale complicated by severe left-sided heart failure and multiple thromboembolic events.Front Cardiovasc Med2026https://conductscience.org/library/papers/42428489PubMed
42364251Right ventricular to pulmonary artery coupling and clinical outcomes after interatrial shunting in heart failure: exploratory analysis of the PRELIEVE study.ESC Heart Fail2026https://conductscience.org/library/papers/42364251PubMed
41984824Heart failure and preserved ejection fraction: pathophysiology, clinical assessment, and management of exercise intolerance.Eur Heart J2026https://conductscience.org/library/papers/41984824PubMed
41887649
Comparison of the efficacy of non-pharmacological interventions for patients with heart failure with preserved ejection fraction: protocol for a systematic review and network meta-analysis of randomised controlled trials.
BMJ Open2026https://conductscience.org/library/papers/41887649PubMed
41682980Patent Foramen Ovale Does Not Affect Left Atrial Pressure in Atrial Fibrillation Ablation Patients.J Clin Med2026https://conductscience.org/library/papers/41682980PubMed
41465899Iatrogenic atrial septal defect following transcatheter edge-to-edge mitral valve repair: A systematic review and meta-analysis.Medicine (Baltimore)2025https://conductscience.org/library/papers/41465899PubMed
41326847Atrial shunt therapy for heart failure: an update review.Heart Fail Rev2025https://conductscience.org/library/papers/41326847PubMed
41181650Efficacy and safety of interatrial shunt treatment for heart failure: A systematic review and meta-analysis.World J Cardiol2025https://conductscience.org/library/papers/41181650PubMed
41000019Easing the Strain: Atrial Function After Atrial Shunting.Circ Heart Fail2025https://conductscience.org/library/papers/41000019PubMed
40896284Time's imprint on the left atrium: aging and atrial myopathy.J Cardiovasc Aging2025https://conductscience.org/library/papers/40896284PubMed
40894364Atrial Shunting for Heart Failure.Struct Heart2025https://conductscience.org/library/papers/40894364PubMed
40857067Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials.ESC Heart Fail2025https://conductscience.org/library/papers/40857067PubMed
40511661Improvement of Hemodynamics and Quality of Life Before and After Interatrial Shunt Devices Implantation for Chronic Heart Failure: A Systematic Review and Meta-analysis.Curr Cardiol Rev2025https://conductscience.org/library/papers/40511661PubMed
40180634Device-based therapies for heart failure with preserved ejection fraction.Heart Fail Rev2025https://conductscience.org/library/papers/40180634PubMed
40155120Diastolic Mitral Regurgitation With Interatrial Left-to-Right Shunt.JACC Case Rep2025https://conductscience.org/library/papers/40155120PubMed
40121540Determinants of cardiac output in health and heart failure.Exp Physiol2025https://conductscience.org/library/papers/40121540PubMed
40061421Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failure.J Soc Cardiovasc Angiogr Interv2025https://conductscience.org/library/papers/40061421PubMed

See all 133 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29142012

GET https://conductscience.org/api/papers/v1/29142012/cited_by?page=2